Order Article Reprints

Hu C-Y, Hung C-F, Chen P-C, Hsu J-Y, Wang C-T, Lai M-D, Tsai Y-S, Shiau A-L, Shieh G-S, Wu C-L. Oct4 and Hypoxia Dual-Regulated Oncolytic Adenovirus Armed with shRNA-Targeting Dendritic Cell Immunoreceptor Exerts Potent Antitumor Activity against Bladder Cancer. Biomedicines. 2023; 11(10):2598. https://doi.org/10.3390/biomedicines11102598

Hu, Che-Yuan, Chi-Feng Hung, Pi-Che Chen, Jia-Yu Hsu, Chung-Teng Wang, Ming-Derg Lai, Yuh-Shyan Tsai, Ai-Li Shiau, Gia-Shing Shieh, and Chao-Liang Wu. 2023. "Oct4 and Hypoxia Dual-Regulated Oncolytic Adenovirus Armed with shRNA-Targeting Dendritic Cell Immunoreceptor Exerts Potent Antitumor Activity against Bladder Cancer" Biomedicines 11, no. 10: 2598. https://doi.org/10.3390/biomedicines11102598

Hu, C.-Y., Hung, C.-F., Chen, P.-C., Hsu, J.-Y., Wang, C.-T., Lai, M.-D., Tsai, Y.-S., Shiau, A.-L., Shieh, G.-S., & Wu, C.-L. (2023). Oct4 and Hypoxia Dual-Regulated Oncolytic Adenovirus Armed with shRNA-Targeting Dendritic Cell Immunoreceptor Exerts Potent Antitumor Activity against Bladder Cancer. Biomedicines, 11(10), 2598. https://doi.org/10.3390/biomedicines11102598